Gut microbiota–derived metabolite trimethylamine N-oxide alters the host epigenome through inhibition of S-adenosylhomocysteine hydrolase
Authors:
Open Access
- 25 July 2025
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (9) , 110521
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL148577)
- NIH National Institute of General Medical Sciences (GM149279)
This publication has 129 references indexed in Scilit:
- Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial CohortCancer, 2024
- The gut microbe-derived metabolite trimethylamine-N-oxide induces aortic valve fibrosis via PERK/ATF-4 and IRE-1α/XBP-1s signaling in vitro and in vivoAtherosclerosis, 2023
- FMO3 and its metabolite TMAO contribute to the formation of gallstonesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- SCD1 regulates the AMPK/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscleJournal of Cellular Physiology, 2019
- Intestinal microbiota in patients with nonalcoholic fatty liver diseaseHepatology, 2013
- S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model systemBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- LC‐MS Data Processing with MAVEN: A Metabolomic Analysis and Visualization EngineCurrent Protocols in Bioinformatics, 2012
- Adenosine deaminase: Functional implications and different classes of inhibitorsMedicinal Research Reviews, 2001
- Homocysteine and Neurologic DiseaseArchives of Neurology, 2000
- Trimethylamine and methylamine as growth substrates for rumen bacteria andMethanosarcina barkeriCurrent Microbiology, 1979